Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-03-17 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +2,359 5,333.39
2020-03-17 Stark David Matthew Exec. VP Chief Legal Officer Sale −2,359 $7.16 $17K 2,974.39
2020-03-17 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −2,359 0
2020-03-17 O'Grady Brendan P. EVP, North America Commercial Option exercise +1,179 15,338.49
2020-03-17 O'Grady Brendan P. EVP, North America Commercial Sale −470 $7.16 $3K 14,868.49
2020-03-17 O'Grady Brendan P. EVP, North America Commercial Option exercise · Restricted Share Units −1,179 0
2020-03-17 Nazzi Gianfranco EVP, International Markets Option exercise +874 20,189.36
2020-03-17 Nazzi Gianfranco EVP, International Markets Sale −345 $7.17 $2K 19,844.36
2020-03-17 Nazzi Gianfranco EVP, International Markets Option exercise · Restricted Share Units −874 0
2020-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +748 45,808.51
2020-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +266 46,074.51
2020-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Sale −380 $7.16 $3K 45,694.51
2020-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Sale −134 $7.16 $960 45,560.51
2020-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −748 0
2020-03-17 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −266 0
2020-03-17 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise +1,179 20,638.7
2020-03-17 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise · Restricted Share Units −1,179 0
2020-03-17 Daniell Richard Exec. VP, European Commercial Option exercise +1,297 11,016
2020-03-17 Daniell Richard Exec. VP, European Commercial Sale −616 $7.17 $4K 10,400
2020-03-17 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −1,297 0

Page 56 of 76 · 1,517 trades